The United States is a major market for medical devices and diagnostic products, and many manufacturers source injection-molded components internationally. When molded medical parts are imported into the U.S., their regulatory treatment depends largely on whether they are components intended for further manufacturing or finished medical devices ready for commercial distribution. This article breaks down the complex regulatory requirements for importing medical device components into the US.
The Dual Regulatory Framework For Importing Medical Molded Parts Into The US
Two separate authorities govern the entry of medical molded parts into the United States. The first is the US Food and Drug Administration (FDA), which regulates the safety and effectiveness of medical devices and reviews FDA-regulated products at the border. The second is US Customs and Border Protection (CBP), which administers entry procedures, duties, and trade enforcement.
These two systems operate in parallel. CBP determines whether a shipment is properly declared, classified, and valued, and it collects applicable duties. The FDA determines whether the product is subject to its requirements and whether the paperwork submitted at entry supports that status. As described in the FDA guidance on importing medical devices, entry data are reviewed for registration and listing status, product codes, and Affirmation of Compliance information. A shipment may therefore clear customs requirements and still be held for FDA review, or the reverse.
Overall, importers benefit from treating the framework as two checkpoints rather than one. Accurate data supplied to both agencies generally determines how smoothly a shipment moves.
Defining "Finished Device" vs. "Unfinished Molded Part/Housing"
The most important distinction in this area is between a finished device and a component. Under FDA regulations, a finished device is one that is suitable for use or capable of functioning, whether or not it is packaged, labeled, or sterilized. A component, by contrast, is a part intended to be included in a finished device and is not itself ready for use in patient care.
A molded housing, frame, or casing that is shipped to a device manufacturer for assembly is generally regarded as an unfinished part. A completed, packaged, and labeled product, such as a disposable medical tool intended for clinical use, is generally regarded as a finished device. The boundary can be less clear for replacement parts and accessories. In such cases, the intended use and the sales channel are key considerations. A part sold to an original equipment manufacturer differs from a part sold directly to hospitals or end users as a replacement item.
This classification matters because it determines which obligations apply. Suppliers of molded parts benefit from confirming with their US customers whether each part is treated as a component or as a device, and from documenting that determination in commercial paperwork.
Import Regulation For Finished Medical Device Vs Raw Molded Parts
| Process Step | Finished Medical Device | Raw Molded Parts/Housing |
|---|---|---|
| Foreign Factory Registration | Mandatory | Exempt in most cases (see conditions below) |
| Product FDA Listing | Mandatory | Exempt under 21 CFR 807.65(a), if conditions are met |
| Border Declarations | Intended Use Code 081.001; plus PM# (510(k)/PMA) where applicable | Intended Use Code 081.007; AoC code CPT |
| Labeling Requirements | Full medical labeling, warnings, and UDI | Country-of-origin marking and commercial identifiers; no device labeling or UDI as a component |
| FDA Inspection Target | Foreign manufacturing facility | Mainly the device maker’s supplier controls; the component maker remains subject to FDA inspection authority |
Regulations for Importing Medical Molded Parts
The Central Provision: 21 CFR 807.65
Under 21 CFR 807.65(a), a manufacturer of raw materials or components used in another company’s device is exempt from establishment registration when it would not otherwise be required to register. The exemption depends on the supplier’s actual activities and the regulatory status of the imported article, so it should not be treated as a blanket exemption for every molder or every molded part.
Conditions and Qualifications of the Exemption
However, several qualifications apply to this exemption.
- Product Code: Use the appropriate FDA product code matching the final intended device category, or use the general code for medical device components.
- Intended Use Code: Declare 081.007, "Component for further manufacturing into a finished medical device."
- Affirmation of Compliance: Use the code CPT (Device Component). It is not used if FDA classifies the part as a finished device.
- Supply relationship: The exemption depends on the facts of each supply relationship and is not granted by the nature of the part alone.
Limits of the Exemption: FDA Inspection Authority
In addition, the exemption is limited in scope. The FDA Compliance Policy Guide Sec. 300.100 addresses the inspection of manufacturers of device components. It indicates that the exemption applies to registration and listing requirements and does not remove the FDA’s authority to inspect. The agency may review a component manufacturer where concerns arise, for example, where a part is linked to a device quality problem.
The finished-device manufacturer or specification developer remains responsible for qualifying suppliers, controlling incoming product, and maintaining the required records. In practice, US customers therefore tend to pass quality expectations down the supply chain through contracts and supplier audits.
Quality Management Expectations
FDA’s Quality Management System Regulation became effective on February 2, 2026, and applies to manufacturers of finished medical devices within its scope. Manufacturers of components or parts are not directly subject to the QMSR solely because they produce those components, although FDA retains inspection authority and finished-device manufacturers may impose supplier-control requirements. ISO 13485 certification is not automatically required for an independent component molder, but ISO 13485:2016 is incorporated by reference into the QMSR for manufacturers covered by the regulation.
Some medical-device customers require component suppliers to maintain ISO 9001 or ISO 13485 certification as part of their own supplier-qualification process. The required standard depends on the customer, component risk, and supplier agreement.
Material Documentation and Traceability
Material documentation and traceability also matter. Buyers typically ask for the following records:
- Resin grade information
- Lot traceability records
- Dimensional inspection reports
These documents support the finished-device manufacturer’s own regulatory file and often influence supplier selection as much as price does.
Core Obligations for Importing Finished Medical Devices
Where a molded product qualifies as a finished device, a broader set of obligations applies.
Establishment Registration And Device Listing
Foreign manufacturers of finished devices are generally required to register their establishments and list their devices with the FDA, as outlined in the FDA resource on who must register, list, and pay the fee.
A foreign establishment must also designate a US agent to serve as a point of contact with the agency. An annual registration fee typically applies. Importers and distributors may have separate registration responsibilities depending on their role.
Device Classification And Premarket Regulation
Devices are assigned to Class I, II, or III according to risk, following the process described in the FDA guidance on classifying a medical device.
- Class I products are generally low risk and are often exempt from premarket notification.
- Class II products typically require a 510(k) submission showing substantial equivalence to an existing device, although some are exempt.
- Class III products, which are generally the highest risk, usually require premarket approval (PMA).
The applicable route depends on the product code and its intended use.
Quality System Requirements
Manufacturers of finished devices are subject to the FDA’s quality management system requirements, now addressed by the Quality Management System Regulation (QMSR), effective February 2, 2026. These requirements cover areas such as design controls, supplier management, production processes, and corrective action. Component manufacturers are generally outside the direct scope of these requirements, although finished-device makers usually apply them to their suppliers by contract.
Labeling and UDI
Finished devices are generally subject to labeling requirements and to the Unique Device Identification (UDI) system, which assigns a standardized identifier to each device and records it in a public database. Labels are expected to be in English and to meet content rules for the device category.
Adverse-Event Reporting
Manufacturers and importers of finished devices are typically required to maintain complaint processes and to report certain deaths, serious injuries, and malfunctions to the FDA. Importers also have record-keeping responsibilities in this area.
Overall, these obligations are significantly more extensive for finished devices than for components, which is the main reason the component-versus-device determination receives early attention.
Step-by-Step Process for Importing Molded Medical Parts into the US
The import process for molded medical parts generally follows a consistent sequence, although details vary by product and trading arrangement.
1- Confirm regulatory status: The parties determine whether the part is a component or a finished device and document the conclusion. This step guides all later filings.
2- Identify the importer of record: The importer of record is normally the owner or purchaser. A licensed customs broker may file the entry on the importer’s behalf and, in permitted circumstances, may be designated as the importer of record. This party is responsible for the accuracy of the entry and for payment of duties.
The CBP importer of record and the FDA initial importer are separate regulatory roles and should not be used interchangeably. The importer of record is normally the owner or purchaser of the merchandise, although a licensed customs broker may act in that capacity when properly designated. An FDA initial importer is the U.S. party that furthers the marketing of a device from a foreign manufacturer to its final delivery or sale and may have separate FDA registration and post-market responsibilities.
3- Prepare commercial documents: These typically include a commercial invoice, packing list, and bill of lading or air waybill. Descriptions are expected to be specific, stating material, function, and intended use.
4- Assign tariff classification: The goods are classified under the Harmonized Tariff Schedule (HTS) of the United States. The classification affects duty rates and FDA screening.
5- Submit the entry data: Entry information is filed electronically with CBP. For FDA-regulated goods, this generally includes the FDA product code, manufacturer details, and Affirmation of Compliance codes. As described in the FDA guidance on Affirmation of Compliance codes, these codes are used to declare items such as registration and listing status or an applicable exemption.
6- Complete pre-arrival filings: For ocean shipments, importer security filing (ISF) data is generally filed no later than 24 hours before cargo is loaded onto the vessel bound for the United States.
7- Undergo FDA and CBP review: The FDA may screen the entry, request additional information, examine the shipment, or allow it to proceed. Shipments associated with firms named in an import alert may be detained.
8- Release and delivery: Once any holds are resolved and duties are paid, the shipment is released for delivery.
Customs Classification, Duties, And Tariff Considerations For Chinese Medical Injection Molded Parts
Tariff classification for molded medical parts depends on what the item is and how it is used. Some components are classified as articles of plastic under the plastics chapter of the tariff schedule, while others are classified according to the apparatus or instrument they are designed to be part of, which often falls under the medical instruments chapter.
Classification of finished devices and recognized accessories is typically more specific. Because the choice of heading affects both duty rates and FDA screening, classification is generally reviewed carefully and is sometimes confirmed in advance through a binding ruling from CBP.
Duties on goods from China generally comprise several layers. The base rate is set by the tariff classification. In addition, many Chinese-origin products are subject to additional tariffs introduced under Section 301 and other trade measures.
The scope and level of these measures have changed several times in recent years, and in some cases specific products have been granted exclusions. It is, therefore, important to confirm the current treatment of a given classification for each shipment rather than assuming from earlier experience.
Several other factors influence landed cost:
- Customs valuation: Duties are generally calculated on the transaction value, so invoices are expected to reflect the actual price paid and any related charges.
- Country of origin: Country of origin may depend on substantial transformation and any applicable product-specific rules. Routing goods through another country does not by itself change their origin.
- Tooling: Where molds are owned by the buyer and shipped separately, the treatment of tooling in valuation and documentation may require separate consideration. If the U.S. buyer supplies a mold or tool free of charge, at a reduced cost, or pays for it separately for use in producing the imported parts, its value may constitute a dutiable assist. The value may need to be apportioned over the imported units, so the arrangement should be reviewed with the customs broker or customs counsel.
- Fees: MPF and other customs fees may apply depending on the entry type and transportation mode; HMF is associated with applicable ocean shipments.
Some buyers have also diversified sourcing across several countries in response to tariff uncertainty. Even so, many buyers continue to source molded parts from China because of its tooling capability, manufacturing scale, and mature supplier base.
Common Causes of Import Delays and How to Prevent Them
Common avoidable causes of delay include incomplete entry data, inconsistent manufacturer information, incorrect product classification, and missing declarations.
- Incorrect or missing Affirmation of Compliance data:
Entries that omit or misstate registration, listing, or exemption information are often flagged for further review. Prevention depends on agreement between supplier and importer, before shipment, on how the part will be declared.
- Misclassification of component versus device:
A part declared as a component when it is sold as a finished device, or the reverse, may result in holds or requests for documentation. Consistent treatment across the contract, invoice, and entry filing is a key consideration.
- Inconsistent manufacturer information:
Differences between the manufacturer named on the invoice, the entry, and the packaging can trigger review. Supplier names and addresses are generally kept uniform across all documents.
- Import alerts and compliance history:
Firms or products linked to an import alert may face detention without physical examination. Importers typically verify the status of their suppliers before placing orders.
- Insufficient supporting documents:
Material certificates, inspection reports, traceability records and quality-system certificates are commonly exchanged between the buyer and supplier for quality control. They are not substitutes for the FDA and CBP entry data required in ACE. If FDA requests additional support, the importer should provide documents relevant to the product’s classification, intended use and admissibility.
In many cases, early coordination between the manufacturer and the importer prevents the majority of these issues.
Conclusion
Importing molded medical parts into the US comes down to getting a few things right early. Decide whether each part is a component or a finished device, declare it consistently across your contract, invoice, and entry filing, and keep your documentation ready for review. Component suppliers are generally exempt from FDA registration and listing, but they are not exempt from inspection, and the details of the entry filing still matter.
MedMoldPro, backed by CKMOLD in China, manufactures non-implant medical, diagnostic, and laboratory plastic components under an ISO 9001:2015-certified quality management system. We can provide agreed material, inspection, traceability, and shipping documentation, while the importer and legal manufacturer remain responsible for regulatory classification and entry requirements.
If you are planning a medical molding project, request a quote from MedMoldPro and send us your part drawings, material requirements, and target volumes. We’ll respond with a plan for manufacturing and export documentation.
Disclaimer: This article provides general information and is not legal or regulatory advice. Requirements change, so confirm your specific import with a licensed customs broker or regulatory consultant.
Last updated: October, 2026